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The objective of the present study was to determine the association between CT phenotypes—emphysema by low attenuation
area and bronchitis by airway wall thickness—and body composition parameters in a large cohort of subjects with and without
COPD. In 452 COPD subjects and 459 subjects without COPD, CT scans were performed to determine emphysema (%LAA),
airway wall thickness (AWT-Pi10), and lung mass. Muscle wasting based on FFMI was assessed by bioelectrical impedance. In
both the men and women with COPD, FFMI was negatively associated with %LAA. FMI was positively associated with AWT-Pi10
in both subjects with and without COPD. Among the subjects with muscle wasting, the percentage emphysema was high, but
the predictive value was moderate. In conclusion, the present study strengthens the hypothesis that the subgroup of COPD cases
with muscle wasting have emphysema. Airway wall thickness is positively associated with fat mass index in both subjects with and
without COPD.
1. Introduction
Chronic obstructive pulmonary disease (COPD) is, besides
a respiratory disorder, recognized as a systemic disease
with extrapulmonary manifestations. In the past, the terms
“pink puﬀer” and “blue bloater” were used to describe
“phenotypes” of COPD, implying that the disease processes
extended beyond the lung [1]. The pink puﬀers were charac-
terized as having emphysematous lungs and a thin body habi-
tus, while the blue bloaters were considered as being obese
and having central cyanosis with little or no emphysema,
often considered as the chronic bronchitis subtype of COPD.
Current techniques utilizing quantitative computed
tomography of thorax (CT) enables us to better characterize
these phenotypes. It has recently been shown that the extent
of emphysema measured by percentage of low attenuation
areas (%LAA) is inversely associated with body mass index
(BMI: body weight/height2) [2]. Another recent paper con-
firmed these data by showing an inverse correlation between
the %LAA and both fat free-mass index (FFMI, a marker
for skeletal muscle mass: fat free mass (FFM)/height2) and
fat mass index (FMI, fat mass (FM)/height2) in subjects
with COPD [3]. Both studies [2, 3] were restricted to heavy
smoking men.
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Airway wall thickness, also derived from the CT scan,
has recently been associated with symptoms of chronic
bronchitis [4]. The relation between airway wall thickness
and body composition is however controversial. Studies have
shown both no [2] and positive [5] correlations between
airway wall percent and BMI. As it is recently shown that
airway wall thickening and emphysema make independent
contributions to symptoms indicative of COPD [6], it
is of relevance to test the discriminative capacity of the
CT phenotypes for markers of extrapulmonary features of
COPD like body composition.
Based on the above-mentioned findings, we hypothesized
that presence of significant emphysematous lesions on a
thoracic CT scan is negatively associated with quantitative
measures of systemic soft tissue, namely, total body fat-free
mass. In addition, we hypothesized that airway wall thickness
is positively associated with BMI and FMI in patients with
COPD, reflecting the bronchitis phenotype. For this purpose,
we examined a large cohort of subjects with COPD and a
cohort of subjects without COPD, both men and women.
2. Methods and Materials
Details of the population characteristics are given elsewhere
[7–9]. Briefly, the study comprised 452 COPD cases and
459 subjects without COPD. Enrollment criteria were self-
reported Caucasian; age >40; current or former smoker
with ≥2.5 pack years of smoking history; no α1-antitrypsin
deficiency. The medical ethical committee approved the
study and written informed consent was obtained from all
subjects. Subjects underwent spirometry according to ATS
standards [4], using a Vitalograph 2160 Spirometer before
and after bronchodilation with 400 μg of salbutamol. The
diagnostic criteria for COPD cases was postbronchodilator
FEV1/FVC ratio less than 0.70 and FEV1 less than 80% of the
predicted. Subjects without COPD had a postbronchodilator
FEV1/FVC ratio greater than 0.70 and FEV1 greater than
80% of predicted [10]. Subjects were assessed at least 6
weeks after any respiratory infection, but were not asked to
withhold regular medication.
Subsequent to the assessment of body height and weight,
whole body impedance was measured using the bio-electrical
impedance method (Bodystat) after overnight fast. For the
calculation of the FFM, a formula for elderly was used for
the control subjects [11], while a COPD-specific formula
was used for the COPD subjects [12]. FM was calculated
by weight minus FFM, FFMI, and FMI was calculated by
respectively FFM and FM divided by heigth2. Muscle wasting
was defined by the cut-oﬀs of Vestbo et al. [13]: FFMI
<17.1 kg/m2 for men and <14.6 kg/m2 for women.
CT scans of thorax were acquired using a GE light-
speed Ultra CT scanner (120 kVp, 200 mA; GE Healthcare,
Milwaukee, WI, USA), at suspended full inspiration using
1 mm slice thickness at 20 mm intervals and reconstructed
using a high-resolution algorithm (Bone). On average there
were 13.4 ± 1.6 CT images per subject. The procedures
for quantitative analyses are previously described [14]. The
extent of emphysema was assessed using custom software
(EmphylxJ). A subject was considered to have emphysema if
the percentage of lung voxels with X-ray attenuation values
were less than −950 HU (%LAA) > 5% [15]. The standard-
ized airway wall thickening at an internal perimeter of 10 mm
(AWT-Pi10) was calculated separately for each subject. To
reduce technical errors associated with very small airways,
only airways with an internal perimeter larger than 6 mm
were included. Lung mass was calculated by multiplying CT
calculated lung density (g/ml) by CT calculated lung volume
(ml). The CT image analyses were performed at the James
Hogg iCAPTURE Centre (Vancouver, BC, Canada). Further
details of the CT analyses can be found elsewhere [4, 10].
2.1. Statistics. All data were expressed as mean± SD, checked
for normality, and if necessary log transformed (%LAA).
Group comparison of continuous variables was tested using
the analysis of variance (ANOVA) test and the post hoc LSD
or the Dunnett-T3 test. Spearman correlation coeﬃcient
was calculated to test associations between CT variables and
body composition parameters. Subsequently, multivariate
linear regression analyses with log(%LAA) and AWT-Pi10
as dependent variables were performed to investigate their
relationship to the body composition variables. Covariables
in these analyses were age, pack years, and lung function.
The prevalence of high emphysema scores after stratification
for muscle wasting was tested by γ2 test. As FFMI was
independently associated with %LAA in the subjects with
COPD, it is of relevance to test the discriminative capacity
of FFMI for %LAA. For this purpose, the area under the
curve (AUC) was calculated by using the receiving operating
characteristic (ROC) curve. An AUC of 0.7–0.8 is considered
to represent reasonable discrimination and an AUC > 0.8
suggest good discrimination [16]. Analyses were performed
using Statistical Package for the Social Sciences (SPSS)
version 17.0 for Windows. A P value < .05 was considered
statistically significant.
3. Results
Characteristics of the study participants are presented in
Table 1. Subjects without COPD were younger and had
higher FEV1, FEV1/FVC, lung mass, weight, and FFMI,
but lower amount of pack years smoked, AWT-Pi10, and
%LAA than subjects with COPD. Within the groups, men
had higher weight, FFMI, lung mass, amount of pack years
smoked and AWT-Pi10 and lower FMI than women. Only in
women with COPD, age and %LAA were lower compared to
men with COPD.
In the male and female COPD cases, %LAA was inversely
correlated with BMI, FFMI, and FMI (Table 2). AWT-Pi10
was positively correlated with BMI, FFMI, and FMI in both
subjects with and without COPD. In addition, only in the
subjects with COPD, lung mass was significantly correlated
with %LAA (r = −0.26, P < .01), and the correlation rema-
ined after correction for FFMI (r = −0.23, P < .01).
In the subjects without COPD, the multivariate regres-
sion analysis revealed that FMI was significantly associated
to %LAA, while both FMI and FFMI were significantly
associated with AWT-Pi10 (Table 3). In the subjects with
COPD, FFMI was a negative covariate for %LAA, while FMI
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Table 1: General characteristics of the study subjects stratified for gender.
Subjects without COPD Subjects with COPD
Men Women Men Women
No. of subjects, n 238 221 299 164
Age, y 55.9 ± 9.6 54.8 ± 9.1 65.2± 9.4∗ 62.6± 9.0∗,†
FEV1, %pred 93.9 ± 8.4 95.9 ± 9.4† 52.6± 17.4∗ 53.1± 16.1∗
FEV1/FVC 0.79 ± 0.04 0.79 ± 0.04 0.52± 0.13∗ 0.54± 0.12∗,†
Weight, kg 86.0 ± 13.1 70.9 ± 12.8† 79.5± 14.9∗ 66.3± 16.0∗,†
BMI, kg/m2 27.0 ± 3.4 25.8 ± 4.5† 25.8± 4.2∗ 24.9 ± 5.6
FFMI, kg/m2 19.3 ± 1.6 16.8 ± 1.7† 18.7± 1.6∗ 15.8± 1.9∗,†
FMI, kg/m2 7.7 ± 2.6 8.9 ± 3.5† 7.1± 2.8∗ 9.1± 3.9†
Lung mass, g 905.2 ± 138.9 753.0 ±113.5† 875.0± 134.5∗ 716.9± 109.2∗,†
No. of pack years, y 21.2 ± 14.4 17.2 ± 12.6† 33.9± 18.6∗ 25.5± 14.2∗,†
AWT-Pi10, cm 0.49 ± 0.03 0.46 ± 0.03† 0.50± 0.03∗ 0.47± 0.03∗,†
%LAA(log transformed) 1.04 ± 1.05 0.72 ± 0.89 12.43± 11.78∗ 9.94± 11.66∗,†
Data are mean ± SD. FEV1: forced expiratory volume in one second, FEV1/FVC: tiﬀeneau index, BMI: body mass index, FFMI: fat-free mass index, FMI: fat
mass index, AWT-Pi10: standardized airway wall thickness at an internal perimeter of 10 mm, %LAA: percentage low attenuation areas less than −950 HU.
∗P < .05 versus subjects without COPD, †P < .05 versus male counterparts.
Table 2: Spearman correlation coeﬃcient between %LAA and AWT-Pi10 and markers of body composition.
Men Women
%LAA AWT-Pi10 %LAA AWT-Pi10
Subjects without COPD
BMI 0.03 0.41† −0.10 0.32†
FFMI −0.02 0.23† −0.05 0.25†
FMI 0.03 0.42† −0.10 0.27†
Subjects with COPD
BMI −0.40† 0.33† −0.34† 0.34†
FFMI −0.43† 0.29† −0.39† 0.37†
FMI −0.34† 0.31† −0.30† 0.32†
BMI: body mass index, FFMI: fat-free mass index, FMI: fat mass index, AWT-Pi10: standardized airway wall thickness at an internal perimeter of 10 mm,
%LAA: percentage low attenuation areas less than −950 HU. Significant correlation: ∗P < .05, †P < .01.
Table 3: Multiple linear regression analyses of change in emphysema level (%LAA) and change in airway wall thickness (AWT-Pi10) by level
fat-free mass index (FFMI) and level of fat mass index (FMI).
Log(%LAA)∗ AWT-Pi10∗∗
Beta SE P value Beta SE P-value
Subjects without COPD
FFMI −0.04 0.02 .528 0.16 0.01 .002
FMI 0.09 0.01 .053 0.22 0.01 <.001
Adjusted R2 0.26 0.33
Subjects with COPD
FFMI −0.28 0.02 .002 0.08 0.02 .460
FMI 0.03 0.01 .686 0.20 0.01 .020
Adjusted R2 0.48 0.30
%LAA: percentage low attenuation areas less than −950 HU, AWT-Pi10: standardized airway wall thickness at an internal perimeter of 10 mm, FFMI: fat-free
mass index, FMI: fat mass index.
∗Adjusted for age, pack year, FEV1 (%pred), and AWT-Pi10,
∗∗Adjusted for age, pack year, FEV1 (%pred), and %LAA.
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Figure 1: The amount of men (a) and women (b) with normal or high %LAA in relation to muscle wasting.
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Figure 2: Receiving operating characteristics for FFMI in the
subjects with COPD.
was a positive covariate for AWT-Pi10. The associations did
not diﬀer between men and women (data not shown).
Of the male COPD cases, 15.5% had muscle wasting;
of these, 88.9% had high emphysema scores (Figure 1). In
women, about 27% of the COPD cases had muscle wasting;
67.4% of them had high emphysema scores. The other way
around, of all the men with high emphysema scores (62.5%),
only 22% of them had muscle wasting. In line, of the 47.5%
of the women with high emphysema scores, about 28% of
them had muscle wasting. Discriminating capacity of FFMI
to predict high %LAA is presented in Figure 2. The AUC for
FFMI in predicting high %LAA was 0.60 (95% confidence
interval (CI): 0.55–0.65; sensitivity: 26.7; specificity: 90.2),
indicating a moderate fit.
4. Discussion
The results of the present study reveal that fat free mass index
decreases as the level of emphysema increases in both men
and women with COPD. This relationship was independent
of age, pack years, FEV1 (%pred), and airway wall thickness.
However, muscle wasting is only moderate discriminative
for the presence of emphysema. Furthermore, airway wall
thickness was positively associated with fat mass index both
in subjects with and without COPD.
An inverse association of %LAA to FFMI and/or FMI has
previously been observed in men with an extreme smoking
history [2, 3]. We have extended this knowledge by showing
that the association applies to both genders and exists also
in subjects with a far less smoking burden (e.g., mean pack
years = 65 in [3] versus 30 in the present study) and degree
of emphysema (e.g., %LAA = 29% in [3] versus 11% in
the present study). Further, we observed that FFMI was
independently associated with level of emphysema. This
finding strengthens the hypothesis of defective regeneration
processes of soft tissue in subjects with COPD and the
emphysema phenotype. Although the reason for this is
not yet known, various hypotheses are brought to mind.
Emphysema is characterized by enlargement of the distal
airspaces, caused by destruction of the airway walls [17]. It
is postulated that the inflammatory response which results
in protease antiprotease imbalance, and therefore tissue
destruction is extended from the lungs to whole body
soft tissue. However, the link between the respiratory and
the systemic inflammatory processes has to be proven yet.
Another hypothesis purports emphysema as an autoimmune
disease aﬀecting the lung and other systemic elastin-rich
tissues in emphysema patients [18]. The aforementioned
hypotheses are based on the assumption that loss of soft
tissue is a consequence of emphysema. Indeed, patients
with severe emphysema undergoing lung volume reduction
surgery showed an increase in fat free mass after 6 months,
implying that the systemic eﬀects of the disease can, at
least partly, be reversed [19]. There are however no con-
vincing data to confirm that muscle wasting is secondary
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to emphysema yet. In fact, it has been shown that anorexia
patients have lower CT density when compared to healthy
subjects [20], pointing to the hypothesis that starvation per
se can induce secondary emphysema. In addition, although
most subjects with muscle wasting had high emphysema
scores, the predictive value of FFMI for emphysema is only
moderate, suggesting that various pathways are involved in
the pathogenesis of emphysema. More research is warranted
to unravel the temporal sequence of muscle wasting, the
presence of emphysema phenotype, and the interrelation
between the two.
In the current study, FMI is a positive covariate of AWT-
Pi10 in both subjects with and without COPD. Results of
previous studies concerning the correlation between airway
wall thickness and BMI are controversial; studies have
shown no [2] and positive correlations [5]. Until now, no
study related airway wall thickness with FMI. The positive
association between the two seen in the present study
strengthens the hypothesis of the bronchitis phenotype as CT
measured airways were associated with symptoms of chronic
bronchitis [15]. However, the association is not disease-
specific, questioning the usefulness of AWT-Pi10 as a specific
marker to phenotype COPD.
The association between the CT phenotypes and body
composition parameters did not diﬀer between men and
women. We have recently shown that there is a gender
specific diﬀerence in both %LAA and AWT-Pi10 [7]. Taken
together, these findings imply that men are more susceptible
to develop emphysema and thicker airway walls while the
extrapulmonary manifestations of the COPD phenotypes are
likely gender independent, at least for body composition.
We would like to address some limitations and strengths
of the study. First, the subjects without COPD were younger
than the subjects with COPD, and even tough age has been
taken into account in the multivariate regression analysis, it
could still influence our findings. Secondly, while COPD is
considered to be a small airways disease and we calculated
AWT-Pi10 using larger airways (Pi > 0.6 cm), studies
have shown that CT estimates of airway wall thickness are
correlated with histological measurements of small airways
[21]. Finally, obese subjects have more subcutaneous fat
through which the X-rays have to penetrate resulting in less
X-ray energy detected by the CT scanners and X-ray “beam
hardening” eﬀects resulting in diﬀerential eﬀects on X-ray
attenuation values. The increased amount of abdominal fat
in obese subjects will also, in the supine position used
during CT assessment, tend to decrease the measured lung
volume. Both these factors will tend to obscure the observed
relationship between %LAA and BMI. However, in the
subjects without COPD, no correlation was found between
%LAA and BMI, implying that the impact of this technical
issue is minimal. The strengths of the present study are the
large number of subjects of both genders with and without
COPD, and the quantitative analysis of the CT scan.
To conclude, the present study strengthens the concept
that COPD cases with muscle wasting are mainly charac-
terized by the emphysema phenotype and decreased lung
mass, although muscle wasting is not discriminative for
emphysema. Airway wall thickness is positively related to
fat mass index in both subjects with and without COPD.
Whether airway wall thickness is a specific marker useful
in phenotyping COPD has to be further investigated. These
findings provide new insights into the systemic patho-
physiology of COPD and its phenotypes.
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